Last updated on August 13th, 2026 at 07:32 pm
Last updated on August 13th, 2026 at 07:32 pm
Low-Dose Lithium News, Podcasts, & Publications
A Double-Blind, Placebo-Controlled, Crossover Study of Low-Dose Lithium in Personality Disorder Diagnosed Patients with Elevated Inflammatory Biomarkers.
News & Announcements
Low-Dose Lithium News, Podcasts, Publications, and Media
Stay up-to-date on Low-Dose Lithium in the News, podcasts, publications, announcements, and media. Read about the Lithium Inflammation Psychiatry (LIP) Research Study at the Karolinska Institute in Stockholm, Sweden. Get updates on low-dose lithium carbonate (150 mg) treatment for anxiety, suicide prevention, early-onset Alzheimer’s disease, neurodegeneration and cognitive function, addiction recovery, and anti-aging benefits. Learn about up-to-date, measurable patient outcomes from our systematic review of low-dose lithium treatment options.
- Lithium, at microdoses, is linked to a wide array of health benefits, including lower rates of suicide, homicide, and various chronic diseases, without significant reported adverse effects.
- Despite the potential health benefits of micro-dosed Lithium, there is a notable lack of regulation and research into its use in drinking water, highlighting a gap in public health policies.
- The historical stigma associated with Lithium, primarily due to its use in treating severe mental disorders, may contribute to the current lack of traction for micro-dosed Lithium as a health supplement.
Micro-dosed Lithium is a relatively under-researched field of water science. Yet it offers a wealth of advantages. Adding a micro-dose of Lithium to tap water could provide numerous health benefits, including improved heart function, bone formation, obesity and diabetes management, reduced risks of Alzheimer’s, and more.
HILL Model Framework for Treating Concussion Neuroinflammation with Low-Dose Lithium
Discover the latest in concussion prevention strategies. Learn how the Hill Model framework treats TBI…
Mental Health Biomarkers and Lithium Research
Crossover Study of Low-Dose Lithium in Personality Disorder Research Team from the Karolinska Institute